Activin A, inhibin A, inhibin B and parturition: Changes of maternal and cord serum levels according to the mode of delivery

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 106, Issue 10, 1999, Pages 1061-1065

  Florio, P ^a   Benedetto, C ^b   Luisi, S ^a   Santuz, M ^d   Di Carlo, C ^c   Marozio, L ^b   Genazzani, A R ^a   Petraglia, F ^d  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^d UNIVERSITY OF UDINE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN A; INHIBIN; INHIBIN A; INHIBIN B; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CESAREAN SECTION; CHILDBIRTH; CLINICAL TRIAL; DELIVERY; FEMALE; HORMONE BLOOD LEVEL; HUMAN; LABOR; MATERNAL SERUM; NORMAL HUMAN; PREGNANCY; PRIORITY JOURNAL; UMBILICAL ARTERY; UMBILICAL CORD BLOOD; VAGINAL DELIVERY;

ACTIVINS; CESAREAN SECTION; DELIVERY, OBSTETRIC; FEMALE; FETAL BLOOD; HUMANS; INHIBINS; LABOR, OBSTETRIC; MALE; PEPTIDES; PREGNANCY; PROSTATIC SECRETORY PROTEINS;

EID: 0009742187     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.1999.tb08114.x     Document Type: Article

References (23)

1. Petraglia F, Calza’ L, Garuti GC et al. Presence and synthesis of inhibin subunits in human decidua. J Clin Endocrinol Metab 1990; 71: 487-491.
2. Petraglia F, Garuti GC, Calza’ L et al. Inhibin subunits in human placenta: localization and messenger ribonucleic acid levels during pregnancy. Am J Obstet Gynecol 1991; 165:750-755.
3. Wallace EM, Riley SC, Crossley JA et al. Dimeric inhibins in amniotic fluid, maternal serum and fetal serum in human pregnancy. J Clin Endocrinol Metab 1997; 82: 218-222.
4. Petraglia F, Garg S, Florio P et al. Activin A and activin B measured in maternal serum, cord blood serum and in amniotic fluid during human pregnancy. Endocr J 1993; 1: 323-328.
5. Muttukrishna S, Fowler PA, George L, Groome NP, Knight PG. Changes in peripheral serum levels of total activin A during menstrual cycle and pregnancy. J Clin Endocrinol Metab 1996; 81: 3328-3334.
6. Petraglia F, Luisi S, Benedetto C et al. Changes of dimeric inhibin B levels in maternal serum throughout healthy gestation and in women with gestational diseases. J Clin Endocrinol Metab 1997; 82: 2991-2995.
7. Petraglia F, Florio P, Nappi C, Genazzani AR. Peptide signalling in human placenta and membranes: Autocrine, paracrine, and endocrine mechanisms. Endocrine Rev 1996; 17: 156-186.
8. Petraglia F, Gallinelli A, De Vita D, Lewis K, Mathews L, Vale W. Activin at parturition: changes of maternal serum levels and evidence for binding sites in placenta and fetal membranes. Obstet Gynecol 1994; 84:278-282.
9. Petraglia F, Di Blasio AM, Florio P et al. High levels of fetal membrane activin BA and activin receptor IIB mRNAs and augmented concentration of amniotic fluid activin A in women in term and preterm labor. J Endocrinol 1997; 154: 95-101.
10. Florio P, Lombardo M, Gallo R et al. Activin A, corlicotmpin-releasing factor and prostaglandin F2 increase immunoreactive oxytocin release from cultured human placental cells. Placenta 1996; 17: 307-311.
11. Petraglia F, Anceschi MM, Calza’ L et al. Inhibin and activin in human fetal membranes: evidence for a local effect on prostaglandin release. J Clin Endocrinol Metab 1993; 77; 542-546.
12. Abe Y. Hasegawa Y, Miyamoto K et al. High concentrations of plasma immunoreactive inhibin during normal pregnancy in women. J Clin Endocrinol Metab 1990; 71: 133-137.
13. Tabei T, Ochiai K, Terashima Y, Takanashi N. Serum levels of inhibin in maternal and umbilical blood during pregnancy. Am J Obstet Gynecol 1991; 164: 896-900.
14. Anderson AM, Toppari J, Haavisto AM, Petersen JH, Simell T, Skaakkebaek S. Longitudinal reproductive hormone profiles in infants: peak of inhibin B levels in infant boys exceeds levels in adult men. J Clin Endocrinol Metab 1998; 83: 675-681.
15. Florio P, Luisi S, Viganò P et al. Healthy women and patients with endometriosis show high levels of inhibin A, inhibin B, and activin A in peritoneal fluid throughout the menstrual cycle. Hum Reprod 1998; 13: 2606-2611.
16. Luisi S, Florio P, Battaglia C et al. Activin A and inhibin B in extra-embryonic: coelomic and amniotic fluids, and maternal serum in early pregnancy. Placenta 1998; 19: 435-438.
17. Plotsky PM, Kiaer A, Sutto SW, Sawchenko PE, Vale W. Central activin administration modulates corticotropin-releasing hormone and adreno-corticotropin secretion. Endocrinol 1991; 128: 2520-2525.
18. Sawchenko PE, Plotsky PM, Cunningham Jr ET, Vaughan J, Rivier J. Vale WW. Inhibin β-immunoreactivity in a visceral sensory system controlling oxytocin secretion. Nature 1988; 344: 315-317.
19. Khalil A, Kaufmann RC, Wortsman J, Winters SJ, Huffman DG. Inhibin in normal and abnormal pregnancy: maternal serum concentration and partial characterization. Am J Obstet Gynecol 1995; 172: 1019-1025.
20. Tuuri T, Eramaa M, Hilden K, Ritvos O. The tissue distribution of activin beta A-and beta B-subunit and follistatin messenger ribonucleic acids suggests multiple sites of action for the activin-follistatin system during human development. J CIin Endocrinol Metab 1994; 78: 1521-1524.
21. Majdic G, Mcneilly AS, Sharpe RM, Evans LE, Groome NP, Saunders PTK. Testicular expression of inhibin and activin subunits and follistatin in the rat and human fetus and during postnatal development in the rat. Endocrinol 1997; 138: 2136-2147.
22. Voutilainen R, Eramaa M, Ritvos O. Hormonally regulated inhibin gene expression in human fetal and adult adrenals. J Clin Endocrinol Metab 1991; 73: 1026-1030.
23. Spencer SJ, Rabinovici J, Mesiano S, Goldsmith PC, Jaffe RB. Activin and inhibin in the human adrenal gland. Regulation and differential effects in fetal and adult cells. J Clin Invest 1992; 90: 142-149.